Why the study?
Does endovascular aneurysm repair (EVAR) prevent aneurysm-related deaths in high-risk patients with abdominal aortic aneurysms?
Does endovascular aneurysm repair (EVAR) prevent aneurysm-related deaths in high-risk patients with abdominal aortic aneurysms?
Endovascular aneurysm repair in high-risk patients provides durable prevention of aneurysm-related deaths at 5 years and beyond.
EVAR may support durable aneurysm-related death prevention in high-risk patients; leaves open randomized confirmation versus contemporary alternatives.
Short-term and midterm clinical outcomes after endovascular repair of abdominal aortic aneurysms (AAAs) have been well documented. Evaluation of longer term outcomes is now possible. Here we describe our initial 100 high-risk patients treated with endovascular aneurysm repair (EVAR), all with a minimum of 5 years of follow-up. A retrospective review of prospectively recorded data in a departmental database was undertaken for the first 100 consecutive EVAR patients with a minimum of 5 years (range, 60-105 months) of follow-up performed between December 1997 and June 2001. Information was obtained from surgical follow-up visits and family doctors' offices. Endovascular repair of AAA in high-risk patients can be achieved with acceptably low postoperative mortality and morbidity. Longer term results in this high-risk cohort suggest that EVAR is effective in preventing aneurysm-related deaths at 5 years and beyond. All late mortalities were due to patients' comorbid diseases.
No takes yet. Share an insight, caveat, or question.
Nagpal et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: